img

Global Cancer Microbiome Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Cancer Microbiome Market Research Report 2024

According to MRAResearch’s new survey, global Cancer Microbiome market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Cancer Microbiome market research.
Key companies engaged in the Cancer Microbiome industry include CD Genomics, Eurofins Scientific, Illumina, Prescient Medicine Holding, Micronoma, Novogene, Oxford Nanopore Technologies, Pacific Biosciences and Qiagen, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Cancer Microbiome were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Cancer Microbiome market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Cancer Microbiome market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


CD Genomics
Eurofins Scientific
Illumina
Prescient Medicine Holding
Micronoma
Novogene
Oxford Nanopore Technologies
Pacific Biosciences
Qiagen
Therma Fisher Scientific
Segment by Type
Next Generation Sequencing
Polymerase Chain Reaction

Segment by Application


Hospitals
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Cancer Microbiome report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Microbiome Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Next Generation Sequencing
1.2.3 Polymerase Chain Reaction
1.3 Market by Application
1.3.1 Global Cancer Microbiome Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Microbiome Market Perspective (2018-2033)
2.2 Cancer Microbiome Growth Trends by Region
2.2.1 Global Cancer Microbiome Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Cancer Microbiome Historic Market Size by Region (2018-2023)
2.2.3 Cancer Microbiome Forecasted Market Size by Region (2024-2033)
2.3 Cancer Microbiome Market Dynamics
2.3.1 Cancer Microbiome Industry Trends
2.3.2 Cancer Microbiome Market Drivers
2.3.3 Cancer Microbiome Market Challenges
2.3.4 Cancer Microbiome Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Microbiome Players by Revenue
3.1.1 Global Top Cancer Microbiome Players by Revenue (2018-2023)
3.1.2 Global Cancer Microbiome Revenue Market Share by Players (2018-2023)
3.2 Global Cancer Microbiome Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cancer Microbiome Revenue
3.4 Global Cancer Microbiome Market Concentration Ratio
3.4.1 Global Cancer Microbiome Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Microbiome Revenue in 2022
3.5 Cancer Microbiome Key Players Head office and Area Served
3.6 Key Players Cancer Microbiome Product Solution and Service
3.7 Date of Enter into Cancer Microbiome Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Microbiome Breakdown Data by Type
4.1 Global Cancer Microbiome Historic Market Size by Type (2018-2023)
4.2 Global Cancer Microbiome Forecasted Market Size by Type (2024-2033)
5 Cancer Microbiome Breakdown Data by Application
5.1 Global Cancer Microbiome Historic Market Size by Application (2018-2023)
5.2 Global Cancer Microbiome Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Cancer Microbiome Market Size (2018-2033)
6.2 North America Cancer Microbiome Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Cancer Microbiome Market Size by Country (2018-2023)
6.4 North America Cancer Microbiome Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cancer Microbiome Market Size (2018-2033)
7.2 Europe Cancer Microbiome Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Cancer Microbiome Market Size by Country (2018-2023)
7.4 Europe Cancer Microbiome Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Microbiome Market Size (2018-2033)
8.2 Asia-Pacific Cancer Microbiome Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Cancer Microbiome Market Size by Region (2018-2023)
8.4 Asia-Pacific Cancer Microbiome Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cancer Microbiome Market Size (2018-2033)
9.2 Latin America Cancer Microbiome Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Cancer Microbiome Market Size by Country (2018-2023)
9.4 Latin America Cancer Microbiome Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Microbiome Market Size (2018-2033)
10.2 Middle East & Africa Cancer Microbiome Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Cancer Microbiome Market Size by Country (2018-2023)
10.4 Middle East & Africa Cancer Microbiome Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 CD Genomics
11.1.1 CD Genomics Company Detail
11.1.2 CD Genomics Business Overview
11.1.3 CD Genomics Cancer Microbiome Introduction
11.1.4 CD Genomics Revenue in Cancer Microbiome Business (2018-2023)
11.1.5 CD Genomics Recent Development
11.2 Eurofins Scientific
11.2.1 Eurofins Scientific Company Detail
11.2.2 Eurofins Scientific Business Overview
11.2.3 Eurofins Scientific Cancer Microbiome Introduction
11.2.4 Eurofins Scientific Revenue in Cancer Microbiome Business (2018-2023)
11.2.5 Eurofins Scientific Recent Development
11.3 Illumina
11.3.1 Illumina Company Detail
11.3.2 Illumina Business Overview
11.3.3 Illumina Cancer Microbiome Introduction
11.3.4 Illumina Revenue in Cancer Microbiome Business (2018-2023)
11.3.5 Illumina Recent Development
11.4 Prescient Medicine Holding
11.4.1 Prescient Medicine Holding Company Detail
11.4.2 Prescient Medicine Holding Business Overview
11.4.3 Prescient Medicine Holding Cancer Microbiome Introduction
11.4.4 Prescient Medicine Holding Revenue in Cancer Microbiome Business (2018-2023)
11.4.5 Prescient Medicine Holding Recent Development
11.5 Micronoma
11.5.1 Micronoma Company Detail
11.5.2 Micronoma Business Overview
11.5.3 Micronoma Cancer Microbiome Introduction
11.5.4 Micronoma Revenue in Cancer Microbiome Business (2018-2023)
11.5.5 Micronoma Recent Development
11.6 Novogene
11.6.1 Novogene Company Detail
11.6.2 Novogene Business Overview
11.6.3 Novogene Cancer Microbiome Introduction
11.6.4 Novogene Revenue in Cancer Microbiome Business (2018-2023)
11.6.5 Novogene Recent Development
11.7 Oxford Nanopore Technologies
11.7.1 Oxford Nanopore Technologies Company Detail
11.7.2 Oxford Nanopore Technologies Business Overview
11.7.3 Oxford Nanopore Technologies Cancer Microbiome Introduction
11.7.4 Oxford Nanopore Technologies Revenue in Cancer Microbiome Business (2018-2023)
11.7.5 Oxford Nanopore Technologies Recent Development
11.8 Pacific Biosciences
11.8.1 Pacific Biosciences Company Detail
11.8.2 Pacific Biosciences Business Overview
11.8.3 Pacific Biosciences Cancer Microbiome Introduction
11.8.4 Pacific Biosciences Revenue in Cancer Microbiome Business (2018-2023)
11.8.5 Pacific Biosciences Recent Development
11.9 Qiagen
11.9.1 Qiagen Company Detail
11.9.2 Qiagen Business Overview
11.9.3 Qiagen Cancer Microbiome Introduction
11.9.4 Qiagen Revenue in Cancer Microbiome Business (2018-2023)
11.9.5 Qiagen Recent Development
11.10 Therma Fisher Scientific
11.10.1 Therma Fisher Scientific Company Detail
11.10.2 Therma Fisher Scientific Business Overview
11.10.3 Therma Fisher Scientific Cancer Microbiome Introduction
11.10.4 Therma Fisher Scientific Revenue in Cancer Microbiome Business (2018-2023)
11.10.5 Therma Fisher Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Cancer Microbiome Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Next Generation Sequencing
Table 3. Key Players of Polymerase Chain Reaction
Table 4. Global Cancer Microbiome Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Cancer Microbiome Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Cancer Microbiome Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Cancer Microbiome Market Share by Region (2018-2023)
Table 8. Global Cancer Microbiome Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Cancer Microbiome Market Share by Region (2024-2033)
Table 10. Cancer Microbiome Market Trends
Table 11. Cancer Microbiome Market Drivers
Table 12. Cancer Microbiome Market Challenges
Table 13. Cancer Microbiome Market Restraints
Table 14. Global Cancer Microbiome Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Cancer Microbiome Market Share by Players (2018-2023)
Table 16. Global Top Cancer Microbiome Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Microbiome as of 2022)
Table 17. Ranking of Global Top Cancer Microbiome Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Cancer Microbiome Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Cancer Microbiome Product Solution and Service
Table 21. Date of Enter into Cancer Microbiome Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cancer Microbiome Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Cancer Microbiome Revenue Market Share by Type (2018-2023)
Table 25. Global Cancer Microbiome Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Cancer Microbiome Revenue Market Share by Type (2024-2033)
Table 27. Global Cancer Microbiome Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Cancer Microbiome Revenue Market Share by Application (2018-2023)
Table 29. Global Cancer Microbiome Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Cancer Microbiome Revenue Market Share by Application (2024-2033)
Table 31. North America Cancer Microbiome Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Cancer Microbiome Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Cancer Microbiome Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Cancer Microbiome Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Cancer Microbiome Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Cancer Microbiome Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Cancer Microbiome Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Cancer Microbiome Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Cancer Microbiome Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Cancer Microbiome Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Cancer Microbiome Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Cancer Microbiome Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Cancer Microbiome Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Cancer Microbiome Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Cancer Microbiome Market Size by Country (2024-2033) & (US$ Million)
Table 46. CD Genomics Company Detail
Table 47. CD Genomics Business Overview
Table 48. CD Genomics Cancer Microbiome Product
Table 49. CD Genomics Revenue in Cancer Microbiome Business (2018-2023) & (US$ Million)
Table 50. CD Genomics Recent Development
Table 51. Eurofins Scientific Company Detail
Table 52. Eurofins Scientific Business Overview
Table 53. Eurofins Scientific Cancer Microbiome Product
Table 54. Eurofins Scientific Revenue in Cancer Microbiome Business (2018-2023) & (US$ Million)
Table 55. Eurofins Scientific Recent Development
Table 56. Illumina Company Detail
Table 57. Illumina Business Overview
Table 58. Illumina Cancer Microbiome Product
Table 59. Illumina Revenue in Cancer Microbiome Business (2018-2023) & (US$ Million)
Table 60. Illumina Recent Development
Table 61. Prescient Medicine Holding Company Detail
Table 62. Prescient Medicine Holding Business Overview
Table 63. Prescient Medicine Holding Cancer Microbiome Product
Table 64. Prescient Medicine Holding Revenue in Cancer Microbiome Business (2018-2023) & (US$ Million)
Table 65. Prescient Medicine Holding Recent Development
Table 66. Micronoma Company Detail
Table 67. Micronoma Business Overview
Table 68. Micronoma Cancer Microbiome Product
Table 69. Micronoma Revenue in Cancer Microbiome Business (2018-2023) & (US$ Million)
Table 70. Micronoma Recent Development
Table 71. Novogene Company Detail
Table 72. Novogene Business Overview
Table 73. Novogene Cancer Microbiome Product
Table 74. Novogene Revenue in Cancer Microbiome Business (2018-2023) & (US$ Million)
Table 75. Novogene Recent Development
Table 76. Oxford Nanopore Technologies Company Detail
Table 77. Oxford Nanopore Technologies Business Overview
Table 78. Oxford Nanopore Technologies Cancer Microbiome Product
Table 79. Oxford Nanopore Technologies Revenue in Cancer Microbiome Business (2018-2023) & (US$ Million)
Table 80. Oxford Nanopore Technologies Recent Development
Table 81. Pacific Biosciences Company Detail
Table 82. Pacific Biosciences Business Overview
Table 83. Pacific Biosciences Cancer Microbiome Product
Table 84. Pacific Biosciences Revenue in Cancer Microbiome Business (2018-2023) & (US$ Million)
Table 85. Pacific Biosciences Recent Development
Table 86. Qiagen Company Detail
Table 87. Qiagen Business Overview
Table 88. Qiagen Cancer Microbiome Product
Table 89. Qiagen Revenue in Cancer Microbiome Business (2018-2023) & (US$ Million)
Table 90. Qiagen Recent Development
Table 91. Therma Fisher Scientific Company Detail
Table 92. Therma Fisher Scientific Business Overview
Table 93. Therma Fisher Scientific Cancer Microbiome Product
Table 94. Therma Fisher Scientific Revenue in Cancer Microbiome Business (2018-2023) & (US$ Million)
Table 95. Therma Fisher Scientific Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Microbiome Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Cancer Microbiome Market Share by Type: 2022 VS 2033
Figure 3. Next Generation Sequencing Features
Figure 4. Polymerase Chain Reaction Features
Figure 5. Global Cancer Microbiome Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Cancer Microbiome Market Share by Application: 2022 VS 2033
Figure 7. Hospitals Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Cancer Microbiome Report Years Considered
Figure 11. Global Cancer Microbiome Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Cancer Microbiome Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Cancer Microbiome Market Share by Region: 2022 VS 2033
Figure 14. Global Cancer Microbiome Market Share by Players in 2022
Figure 15. Global Top Cancer Microbiome Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Microbiome as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Cancer Microbiome Revenue in 2022
Figure 17. North America Cancer Microbiome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Cancer Microbiome Market Share by Country (2018-2033)
Figure 19. United States Cancer Microbiome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Cancer Microbiome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Cancer Microbiome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Cancer Microbiome Market Share by Country (2018-2033)
Figure 23. Germany Cancer Microbiome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Cancer Microbiome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Cancer Microbiome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Cancer Microbiome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Cancer Microbiome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Cancer Microbiome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Cancer Microbiome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Cancer Microbiome Market Share by Region (2018-2033)
Figure 31. China Cancer Microbiome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Cancer Microbiome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Cancer Microbiome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Cancer Microbiome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Cancer Microbiome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Cancer Microbiome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Cancer Microbiome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Cancer Microbiome Market Share by Country (2018-2033)
Figure 39. Mexico Cancer Microbiome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Cancer Microbiome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Cancer Microbiome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Cancer Microbiome Market Share by Country (2018-2033)
Figure 43. Turkey Cancer Microbiome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Cancer Microbiome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. CD Genomics Revenue Growth Rate in Cancer Microbiome Business (2018-2023)
Figure 46. Eurofins Scientific Revenue Growth Rate in Cancer Microbiome Business (2018-2023)
Figure 47. Illumina Revenue Growth Rate in Cancer Microbiome Business (2018-2023)
Figure 48. Prescient Medicine Holding Revenue Growth Rate in Cancer Microbiome Business (2018-2023)
Figure 49. Micronoma Revenue Growth Rate in Cancer Microbiome Business (2018-2023)
Figure 50. Novogene Revenue Growth Rate in Cancer Microbiome Business (2018-2023)
Figure 51. Oxford Nanopore Technologies Revenue Growth Rate in Cancer Microbiome Business (2018-2023)
Figure 52. Pacific Biosciences Revenue Growth Rate in Cancer Microbiome Business (2018-2023)
Figure 53. Qiagen Revenue Growth Rate in Cancer Microbiome Business (2018-2023)
Figure 54. Therma Fisher Scientific Revenue Growth Rate in Cancer Microbiome Business (2018-2023)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed